SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005967
Filing Date
2024-02-13
Accepted
2024-02-13 06:50:19
Documents
16
Period of Report
2024-02-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56639
2 ex99-1.htm EX-99.1 25293
  Complete submission text file 0001493152-24-005967.txt   310854

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cing-20240212.xsd EX-101.SCH 3781
4 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cing-20240212_def.xml EX-101.DEF 26635
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cing-20240212_lab.xml EX-101.LAB 36718
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cing-20240212_pre.xml EX-101.PRE 25259
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5636
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 24622522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)